688399 硕世生物
2026/03 - 三个月
人民币(K¥)
2025/12
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
经营活动产生之现金流量净额(2,648)30,341145,925(113,144)1,964,878
投资活动产生之现金流量净额(143,805)(193,286)(873,013)462,348(717,888)
筹资活动产生之现金流量净额143,148(162,107)(94,756)55,259(667,426)
汇率变动对现金及现金等价物的影响(3,109)(1,443)850(1,266)757
现金及现金等价物净增加/(减少)(6,413)(326,495)(820,994)403,197580,322
期初现金及现金等价物余额483,513810,0081,631,0021,227,805647,483
期末现金及现金等价物余额477,100483,513810,0081,631,0021,227,805